Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases-Reference-Cited by-同舟云学术

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

Author:

Liu Ting-Hui¹,Wu Jheng-Yan²^ORCID,Huang Po-Yu³,Hsu Wan-Hsuan³^ORCID,Chuang Min-Hsiang³,Tsai Ya-Wen⁴⁵,Lai Chih-Cheng⁶⁷^ORCID,Huang Chun-Yen⁸

Affiliation:

1. Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan

2. Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan

3. Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

4. Center for Integrative Medicine, Chi Mei Medical Center, Tainan, Taiwan

5. Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung, Taiwan

6. Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan

7. School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan

8. Department of Emergency Medicine, Chi Mei Medical Center, Tainan, Taiwan

Funder

no funding

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

Reference35 articles.

1. World Health ORganization. [cited 2023 Feb 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

4. Risk factors for COVID-19: a systematic mapping study;Rosero PA;Stud Health Technol Inform,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献